PL2197456T3 - Kompozycje oftalmiczne na bazie polisacharydu z nasion tamaryndowca i kwasu hialuronowego - Google Patents

Kompozycje oftalmiczne na bazie polisacharydu z nasion tamaryndowca i kwasu hialuronowego

Info

Publication number
PL2197456T3
PL2197456T3 PL08835989T PL08835989T PL2197456T3 PL 2197456 T3 PL2197456 T3 PL 2197456T3 PL 08835989 T PL08835989 T PL 08835989T PL 08835989 T PL08835989 T PL 08835989T PL 2197456 T3 PL2197456 T3 PL 2197456T3
Authority
PL
Poland
Prior art keywords
hyaluronic acid
combination
tamarind seed
compositions based
seed polysaccharide
Prior art date
Application number
PL08835989T
Other languages
English (en)
Polish (pl)
Inventor
Prete Antonio Del
Marco Sanso
Original Assignee
Hmfra Hungary Korlatolt Feleloessegue Tarsasag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hmfra Hungary Korlatolt Feleloessegue Tarsasag filed Critical Hmfra Hungary Korlatolt Feleloessegue Tarsasag
Publication of PL2197456T3 publication Critical patent/PL2197456T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL08835989T 2007-10-02 2008-10-02 Kompozycje oftalmiczne na bazie polisacharydu z nasion tamaryndowca i kwasu hialuronowego PL2197456T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000510A ITRM20070510A1 (it) 2007-10-02 2007-10-02 Composizioni oftalmiche a base di polisaccaride del seme di tamarindo e acido ialuronico.
EP08835989A EP2197456B1 (en) 2007-10-02 2008-10-02 Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid
PCT/IT2008/000626 WO2009044423A1 (en) 2007-10-02 2008-10-02 Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid

Publications (1)

Publication Number Publication Date
PL2197456T3 true PL2197456T3 (pl) 2012-07-31

Family

ID=40314052

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08835989T PL2197456T3 (pl) 2007-10-02 2008-10-02 Kompozycje oftalmiczne na bazie polisacharydu z nasion tamaryndowca i kwasu hialuronowego

Country Status (14)

Country Link
US (1) US8455462B2 (OSRAM)
EP (1) EP2197456B1 (OSRAM)
JP (1) JP5542674B2 (OSRAM)
KR (1) KR101570966B1 (OSRAM)
AT (1) ATE499106T1 (OSRAM)
CA (1) CA2701721C (OSRAM)
DE (1) DE602008005173D1 (OSRAM)
ES (1) ES2361529T3 (OSRAM)
IT (1) ITRM20070510A1 (OSRAM)
MX (1) MX2010003488A (OSRAM)
PL (1) PL2197456T3 (OSRAM)
PT (1) PT2197456E (OSRAM)
RU (1) RU2493855C2 (OSRAM)
WO (1) WO2009044423A1 (OSRAM)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602006006424D1 (de) * 2005-02-09 2009-06-04 Safilens S R L Ackung zur aufbewahrung und pflege einer kontaktlinse
IT1396607B1 (it) * 2009-11-16 2012-12-14 Hmfra Hungary Ltd Liability Company Preparazioni oftalmiche a base di bdnf (brain-derived neurotrophic factor) e loro uso.
CA2800383C (en) * 2010-05-24 2019-06-25 Indena S.P.A. Tamarind seed polysaccharide for use in the treatment of inflammatory diseases
CA2800382C (en) * 2010-05-24 2019-09-17 Indena S.P.A. Tamarind seed polysaccharide for use in the treatment of microbial infections
FR2963240B1 (fr) * 2010-07-28 2013-03-15 Horus Pharma Composition a usage topique sans conservateur comprenant de l'acide hyaluronique
IT1404145B1 (it) * 2010-12-27 2013-11-15 Altergon Sa Composizioni di acido ialuronico stabilizzate verso l'azione di degradazione del calore o degli enzimi
EP2883931A1 (en) * 2013-12-12 2015-06-17 Omya International AG Improved gel stability
US20170027980A1 (en) 2014-04-15 2017-02-02 Novintethical Pharma Sa Composition based on xyloglucan and proteins for the treatment of intestinal disorders
US11623008B2 (en) * 2014-08-20 2023-04-11 Professional Compounding Centers Of America Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
ES2705692T3 (es) 2015-06-11 2019-03-26 Novintethical Pharma Sa Composiciones nasales tópicas que contienen xiloglucanos para usar como descongestionantes
TW201707719A (zh) * 2015-07-13 2017-03-01 國立大學法人東北大學 視神經保護用組成物
AR108280A1 (es) 2016-05-05 2018-08-08 Acraf Composición oftálmica que comprende una combinación sinérgica de glucógeno y ácido hialurónico o sal del mismo
IT201600108848A1 (it) * 2016-10-27 2018-04-27 Giuliani Spa Composizioni dermatologiche
US10702578B2 (en) * 2017-08-02 2020-07-07 Shilpa Medicare Limited Ophthalmic compositions of cyclosporine
US11129862B2 (en) * 2017-08-30 2021-09-28 Johnson & Johnson Consumer Inc. Ophthalmic compositions
EP3823581A1 (en) * 2018-07-18 2021-05-26 ATG 20 S.r.l. Composition comprising glycyrrhin and cosmetic and pharmaceutical uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80298A (en) * 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
IT1283911B1 (it) * 1996-02-05 1998-05-07 Farmigea Spa Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
WO1999015210A2 (en) * 1997-09-26 1999-04-01 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
HRP20010309B1 (en) * 1998-12-23 2005-06-30 Idea Ag Improved formulation for topical non-invasive application in vivo
US7244768B2 (en) * 2003-10-03 2007-07-17 Allergan, Inc. Compositions and methods comprising prostaglandin related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia
DE602006006424D1 (de) * 2005-02-09 2009-06-04 Safilens S R L Ackung zur aufbewahrung und pflege einer kontaktlinse
TWI393567B (zh) * 2005-03-31 2013-04-21 Bausch & Lomb 治療乾眼之組合物及相關之製造方法及使用方法

Also Published As

Publication number Publication date
EP2197456B1 (en) 2011-02-23
US8455462B2 (en) 2013-06-04
ITRM20070510A1 (it) 2009-04-03
MX2010003488A (es) 2010-08-31
KR101570966B1 (ko) 2015-11-23
DE602008005173D1 (de) 2011-04-07
RU2010117173A (ru) 2011-11-10
PT2197456E (pt) 2011-05-18
KR20100091151A (ko) 2010-08-18
RU2493855C2 (ru) 2013-09-27
JP2010540619A (ja) 2010-12-24
EP2197456A1 (en) 2010-06-23
WO2009044423A1 (en) 2009-04-09
CA2701721A1 (en) 2009-04-09
ES2361529T3 (es) 2011-06-17
CA2701721C (en) 2016-02-23
ATE499106T1 (de) 2011-03-15
JP5542674B2 (ja) 2014-07-09
US20100279981A1 (en) 2010-11-04

Similar Documents

Publication Publication Date Title
PT2197456E (pt) Composi??es oft?lmicas baseadas em polissac?rido de semente de tamarindo e ?cido hialur?nico
MY159463A (en) Method and composition for treating ocular hypertension and glaucoma
MY210233A (en) Methods and compositions for topical delivery
IN2012DN03632A (OSRAM)
JP2010540619A5 (OSRAM)
MX2010004834A (es) Composiciones de analogos de prostaglandina y metodos para tratar las condiciones relacionadas al epitelio.
BRPI0519508A2 (pt) análogos de aminopirazina para tratamento de glaucoma e outras doenças ou condições mediadas por rho cinase
MX2009004362A (es) Compuestos mediante benzoilo amino heterociclilo util en el tratamiento de una enfermedad a traves de glk.
TN2011000416A1 (en) Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
WO2010126626A3 (en) Dual mechanism inhibitors for the treatment of disease
MX2019000586A (es) Virus adenoasociados (aav) sflt-1 para usarse en el tratamiento de degeneración macular relacionada con la edad (amd).
UA95105C2 (ru) Применение производного лактамида для снижения токсичности в препарате, который может соприкасаться с кожей или глазами человека или животного, производные лактамида и способы их получения
TW200833341A (en) 6-aminoimidazo[1,2-b]pyridazine analogs as rho kinase inhibitors for the treatment of rho kinase-mediated diseases and conditions
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
WO2009024677A3 (fr) Utilisation d ' acide hyaluronique pour la preparation de compositions destinees a l' amelioration de la fonction de protection de la peau, de l' oeil et des muqueuses
MX2011014025A (es) Composicion farmaceutica que comprende sales de rotigotina (acidio o na), especialmente para iontoforesis.
MX2012003759A (es) Metodos y composiciones para tratamiento de fibrosis ocular.
MY149505A (en) Hyaluronic acid binary mixtures and therapeutic use thereof
NO20083905L (no) Nye pyron-indol derivater og fremgangsmate for deres fremstilling
TNSN08321A1 (en) Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof
UA95224C2 (ru) Антацидная фармацевтическая композиция в порошковой форме, фармацевтическое средство, ее содержащее, и способ ее получения
CA3154083A1 (en) Methods of promoting scfa production by gut microbiota
SG179131A1 (en) Modified erythropoietin to which water-soluble long-chain molecule is added
NO20081035L (no) Ikke-invasivt legemiddel-leveringssystem som anvender en fast sammensetning pa vevet i bakre segment av oyet
TNSN06293A1 (en) Ophthalmic solution comprising sodium carboxymethylcellulose and hydroxypropylmethylcellulose